Literature DB >> 11829748

CD38 is the major enzyme responsible for synthesis of nicotinic acid-adenine dinucleotide phosphate in mammalian tissues.

Eduardo N Chini1, Claudia C S Chini, Ichiro Kato, Shin Takasawa, Hiroshi Okamoto.   

Abstract

In the present study, we have determined the role of the enzyme CD38 upon the synthesis of the Ca(2+)-releasing nucleotide nicotinic acid-adenine dinucleotide phosphate (NAADP). In rat tissues, we observed that the capacity for NAADP synthesis could be co-immunoprecipitated with CD38 using an anti-CD38 antibody. Furthermore, we observed that several tissues from CD38 knockout mice had no capacity for the synthesis of this nucleotide. In addition, CD38 was also identified as the major enzyme responsible for the synthesis of the second messenger cyclic ADP-ribose. These observations lead to the conclusion that CD38 is the major enzyme responsible for the synthesis of NAADP and cyclic ADP-ribose, and raises the possibility of a new signalling pathway where two different Ca(2+)-releasing nucleotides are synthesized by the same enzyme.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11829748      PMCID: PMC1222368          DOI: 10.1042/0264-6021:3620125

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Widespread occurrence in animal tissues of an enzyme catalyzing the conversion of NAD+ into a cyclic metabolite with intracellular Ca2+-mobilizing activity.

Authors:  N Rusinko; H C Lee
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

2.  Cell signalling. A tale of two messengers.

Authors:  M J Berridge
Journal:  Nature       Date:  1993-09-30       Impact factor: 49.962

Review 3.  NAADP-induced calcium release in sea urchin eggs.

Authors:  A Galione; S Patel; G C Churchill
Journal:  Biol Cell       Date:  2000-07       Impact factor: 4.458

4.  Nicotinate-adenine dinucleotide phosphate-induced Ca(2+)-release does not behave as a Ca(2+)-induced Ca(2+)-release system.

Authors:  E N Chini; T P Dousa
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

5.  Identification of cyclic ADP-ribose-dependent mechanisms in pancreatic muscarinic Ca(2+) signaling using CD38 knockout mice.

Authors:  Y Fukushi; I Kato; S Takasawa; T Sasaki; B H Ong; M Sato; A Ohsaga; K Sato; K Shirato; H Okamoto; Y Maruyama
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

6.  Widespread distribution of binding sites for the novel Ca2+-mobilizing messenger, nicotinic acid adenine dinucleotide phosphate, in the brain.

Authors:  S Patel; G C Churchill; T Sharp; A Galione
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

7.  Unique inactivation properties of NAADP-sensitive Ca2+ release.

Authors:  A A Genazzani; R M Empson; A Galione
Journal:  J Biol Chem       Date:  1996-05-17       Impact factor: 5.157

8.  Nicotinic acid-adenine dinucleotide phosphate mobilizes Ca2+ from a thapsigargin-insensitive pool.

Authors:  A A Genazzani; A Galione
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

9.  Nicotinate adenine dinucleotide phosphate (NAADP) triggers a specific calcium release system in sea urchin eggs.

Authors:  E N Chini; K W Beers; T P Dousa
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

10.  Enzymatic synthesis and degradation of nicotinate adenine dinucleotide phosphate (NAADP), a Ca(2+)-releasing agonist, in rat tissues.

Authors:  E N Chini; T P Dousa
Journal:  Biochem Biophys Res Commun       Date:  1995-04-06       Impact factor: 3.575

View more
  29 in total

Review 1.  NAD - new roles in signalling and gene regulation in plants.

Authors:  Lee Hunt; Felicitas Lerner; Mathias Ziegler
Journal:  New Phytol       Date:  2004-07       Impact factor: 10.151

Review 2.  NAD and the aging process: Role in life, death and everything in between.

Authors:  Claudia C S Chini; Mariana G Tarragó; Eduardo N Chini
Journal:  Mol Cell Endocrinol       Date:  2016-11-05       Impact factor: 4.102

3.  Nicotinic acid-adenine dinucleotide phosphate-sensitive calcium stores initiate insulin signaling in human beta cells.

Authors:  James D Johnson; Stanley Misler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-15       Impact factor: 11.205

4.  Inhibition of CD38 with the Thiazoloquin(az)olin(on)e 78c Protects the Heart against Postischemic Injury.

Authors:  James Boslett; Nikhil Reddy; Yasmin A Alzarie; Jay L Zweier
Journal:  J Pharmacol Exp Ther       Date:  2019-01-11       Impact factor: 4.030

Review 5.  CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets.

Authors:  Deepak A Deshpande; Alonso G P Guedes; Frances E Lund; Subbaya Subramanian; Timothy F Walseth; Mathur S Kannan
Journal:  Pharmacol Ther       Date:  2016-12-07       Impact factor: 12.310

6.  The action of extracellular NAD+ on gluconeogenesis in the perfused rat liver.

Authors:  Adriana G Martins; Jorgete Constantin; Fabrício Bracht; Ana Maria Kelmer-Bracht; Adelar Bracht
Journal:  Mol Cell Biochem       Date:  2006-04-21       Impact factor: 3.396

7.  Channelling of substrate promiscuity of the skeletal-muscle ADP-ribosyl cyclase isoform.

Authors:  Ingrid Bacher; Andreas Zidar; Martin Kratzel; Martin Hohenegger
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

Review 8.  CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions.

Authors:  Eduardo Nunes Chini
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Nicotinic acid-adenine dinucleotide phosphate activates the skeletal muscle ryanodine receptor.

Authors:  Martin Hohenegger; Josef Suko; Regina Gscheidlinger; Helmut Drobny; Andreas Zidar
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

10.  Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide.

Authors:  Yo Sasaki; Bhupinder P S Vohra; Frances E Lund; Jeffrey Milbrandt
Journal:  J Neurosci       Date:  2009-04-29       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.